COMPANY
REVA Medical
Timeline
- Trial start Not phased (device or behavioral study): MOTIV BTK Randomized Controlled Trial source ↗
- Trial start Not phased (device or behavioral study): FANTOM Post Market Clinical Trial source ↗
- Trial start Not phased (device or behavioral study): Safety & Performance Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold source ↗
- Trial start Not phased (device or behavioral study): Pilot Study of the Fantom Bioresorbable Scaffold (FANTOM I) source ↗
- Trial start Not phased (device or behavioral study): ReZolve2 Clinical Investigation source ↗
- Trial start Not phased (device or behavioral study): Safety Study of a Bioresorbable Coronary Stent source ↗
Clinical trials (lead sponsor) 6
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT05406622 | MOTIV BTK Randomized Controlled Trial | Not phased (device or behavioral study) | Active, not recruiting | Jun 10, 2022 | Apr 30, 2026 (actual) |
| NCT02539966 | Safety & Performance Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold | Not phased (device or behavioral study) | Completed | 2015-03 | 2019-08 (actual) |
| NCT03587922 | FANTOM Post Market Clinical Trial | Not phased (device or behavioral study) | Unknown status (ClinicalTrials.gov) | May 1, 2018 | May 1, 2025 (estimated) |
| NCT01262703 | Safety Study of a Bioresorbable Coronary Stent | Not phased (device or behavioral study) | Completed | 2011-12 | 2013-10 (actual) |
| NCT02512003 | Pilot Study of the Fantom Bioresorbable Scaffold (FANTOM I) | Not phased (device or behavioral study) | Completed | 2014-12 | 2015-07 (actual) |
| NCT01845311 | ReZolve2 Clinical Investigation | Not phased (device or behavioral study) | Completed | 2013-04 | 2014-01 (actual) |
NIH awards 1
- NIH award 1R43HL075925-01 FY2004: $150,000 awarded for that fiscal year; activity R43 (SBIR); PI ZELTINGER, JOAN K; recipient as written: REVA MEDICAL, INC., SAN DIEGO, CA. Radio-opaque Resorbable Stents source ↗